Study to Evaluate Bioactive Peptides' Effect on Digestive Discomfort Symptoms of the Elderly
NCT04450979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2022-04-14
Summary
This trial will investigate the potential of a bioactive peptide to reduce symptoms of digestive discomfort in a generally healthy elderly population. Participants will consume the bioactive peptide for 12 weeks and various measures indicating an improvement in health and well being will be taken throughout the trial. It is believed that consumption of the study product will reduce the severity of digestive discomfort, reduce chronic inflammation, improve blood glucose metabolism and improve physical performance.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Bioactive hydrolysate
Participants given a bioactive vegetable hydrolysate to take one dose each morning and one dose each evening for the duration of the study.
Sponsors & Collaborators
-
Atlantia Food Clinical Trials
collaborator INDUSTRY -
Nuritas Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-14
- Primary Completion
- 2016-10-28
- Completion
- 2017-01-20
More Related Trials
-
Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones
NCT00576589 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants
NCT06887010 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult Participants
NCT04898101 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04183686 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04536961 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects
NCT04804904 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778
NCT02858271 ·Status: COMPLETED ·Phase: PHASE1
-
Supersaturation and Precipitation of Diclofenac in the Stomach of Healthy Volunteers
NCT02007161 ·Status: UNKNOWN ·Phase: NA
-
A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function
NCT01516047 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Metabolism, Excretion and Absolute Bioavailability
NCT03250039 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
NCT07312799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
NCT07312773 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
NCT01267071 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
NCT04735913 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012
NCT05017987 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)
NCT01470690 ·Status: COMPLETED ·Phase: PHASE1
-
A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001
NCT03150498 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults
NCT01050127 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of [14C]X842 in Healthy Adult Male Subjects
NCT07107672 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Pharmacokinetic Study of Final Formulations of ATX-101
NCT01632917 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
NCT07338214 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of CC-292
NCT02433457 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects
NCT00968422 ·Status: COMPLETED ·Phase: PHASE1
-
Mass-balance Study of [14C]-APD421 in Healthy Volunteers
NCT02881840 ·Status: COMPLETED ·Phase: PHASE1
-
Gut Transit Effect on Enterohepatic Circulation
NCT03501498 ·Status: COMPLETED ·Phase: NA